KRAS and malignant colon neoplasm: Our study builds upon prior studies by examining the ability of TNTs to mediate intercellular transfer of mutant KRAS protein in colon cancer cells with endogenous wild-type KRAS. A schematic depicting this process is provided in Figure S7.